• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G447
Device Problems Inappropriate/Inadequate Shock/Stimulation (1574); Inaccurate Synchronization (1609)
Patient Problems Ventricular Fibrillation (2130); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/07/2023
Event Type  Injury  
Event Description
It was reported that anti-tachycardia pacing (atp) and ventricular shock therapy was delivered to convert an arrhythmia.The arrhythmia was detected in the ventricular tachycardia (vt) zone after which two anti-tachycardia pacing (atp) therapies were delivered, which then accelerated the arrhythmia into the ventricular fibrillation (vf) zone and was successfully converted with a 41 j shock.No adverse patient effects were reported.The device remains implanted.
 
Manufacturer Narrative
This investigation is complete.Should additional information become available this investigation will be updated.
 
Event Description
It was reported that anti-tachycardia pacing (atp) and ventricular shock therapy was delivered to convert an arrhythmia.The arrhythmia was detected in the ventricular tachycardia (vt) zone after which two anti-tachycardia pacing (atp) therapies were delivered, which then accelerated the arrhythmia into the ventricular fibrillation (vf) zone and was successfully converted with a 41 j shock.No adverse patient effects were reported.The device remains implanted.
 
Manufacturer Narrative
This report is being filed to update the patient identifier.
 
Event Description
It was reported that anti-tachycardia pacing (atp) and ventricular shock therapy was delivered to convert an arrhythmia.The arrhythmia was detected in the ventricular tachycardia (vt) zone after which two anti-tachycardia pacing (atp) therapies were delivered, which then accelerated the arrhythmia into the ventricular fibrillation (vf) zone and was successfully converted with a 41 j shock.No adverse patient effects were reported.The device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONATE X4 CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17690966
MDR Text Key322740327
Report Number2124215-2023-48306
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberG447
Device Catalogue NumberG447
Device Lot Number291252
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/03/2023
Initial Date FDA Received09/06/2023
Supplement Dates Manufacturer Received09/11/2023
10/12/2023
Supplement Dates FDA Received09/11/2023
10/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/04/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age75 YR
-
-